DeepMed Research

Intercell Usa, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1997-01-01

Employees: 112

Market Cap: -

Website: http://www.iomai.com

Clinical Trials

Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: A/H5N1 Antigen
Drug: Vaccine Enhancement Patch

First Posted Date: 2011-05-13

Last Posted Date: 2012-10-18

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 276

Registration Number: NCT01353534

Locations: 🇦🇹
Privatklinik Leech, Graz, Austria
🇦🇹
Medical University of Vienna, Vienna, Austria
🇧🇪
Antwerp University - Campus Drie Eiken, Antwerp, Belgium

and more 2 locations

Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch

Phase 2

Completed

Conditions: Diarrhea

Interventions: Biological: Placebo
Biological: Heat-Labile Enterotoxin of E. coli (LT)

First Posted Date: 2010-02-12

Last Posted Date: 2020-02-10

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 600

Registration Number: NCT01067781

Locations: 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸
Miami Research Associates, South Miami, Florida, United States
🇺🇸
Clinical Trials of Texas, San Antonio, Texas, United States

and more 2 locations

Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study

Phase 2

Completed

Conditions: Traveler's Diarrhea

Interventions: Biological: TD Vaccine System

First Posted Date: 2009-12-29

Last Posted Date: 2012-03-14

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 723

Registration Number: NCT01040325

Locations: 🇮🇳
Dr. Tito's Health Care and Diagnostic Centre, Goa, India
🇮🇳
Wellesley Medicentre, Kolkata, India
🇮🇳
Prabhugaunker's Clinic, Goa, India

and more 9 locations

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study

Phase 3

Completed

Conditions: Travelers' Diarrhea

Interventions: Biological: TD Vaccine System

First Posted Date: 2009-10-12

Last Posted Date: 2012-03-14

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 2036

Registration Number: NCT00993681

Locations: 🇬🇧
Synexus Midlands Clinical Research Center, Edgbaston, Birmingham, United Kingdom
🇲🇽
Roberto Maxwell's Office, San Miguel de Allende, Guanajuato, Mexico
🇩🇪
Berliner Centrum Reise & Tropenmedizin, Berlin, Germany

and more 17 locations

A/H5N1/LT Dose Ranging Study

Phase 2

Completed

Conditions: Pandemic Influenza

Interventions: Biological: A/H5N1
Biological: LT Adjuvant Patch

First Posted Date: 2009-05-27

Last Posted Date: 2021-12-10

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 500

Registration Number: NCT00908687

Locations: 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸
Solano Clinical Research, Vallejo, California, United States

and more 3 locations

Traveler's Diarrhea (TD) Automated Process

Phase 2

Completed

Conditions: Prevention of Travelers' Diarrhea

Interventions: Biological: heat-labile enterotoxin of E. coli (LT)
Biological: Placebo

First Posted Date: 2008-09-12

Last Posted Date: 2020-01-29

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 120

Registration Number: NCT00751777

Locations: 🇺🇸
Solano Clinical Research, Vallejo, California, United States
🇺🇸
Miami Research Associates, South Miami, Florida, United States
🇺🇸
Clinical Trials of Texas, San Antonio, Texas, United States

Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study

Phase 2

Completed

Conditions: Traveler's Diarrhea

First Posted Date: 2008-05-06

Last Posted Date: 2012-03-14

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 406

Registration Number: NCT00672035

Locations: 🇺🇸
Solano Clinical Research, Davis, California, United States
🇺🇸
Radiant Research - Cincinnati, Cincinnati, Ohio, United States
🇺🇸
QUEST Research Institute, Bingham Farms, Michigan, United States

and more 2 locations

LT Vaccine Patch Self-Administration Study

Phase 2

Completed

Conditions: Prevention of Travelers' Diarrhea

Interventions: Biological: heat-labile enterotoxin of E. coli (LT)

First Posted Date: 2007-11-30

Last Posted Date: 2020-03-30

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 160

Registration Number: NCT00565461

Locations: 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
🇺🇸
Miami Research Associates, South Miami, Florida, United States
🇺🇸
Arkansas Medical Research Testing, Little Rock, Arkansas, United States

A/H5N1 Dose Ranging Study With Adjuvant Patch

Phase 1

Completed

Conditions: Pandemic Influenza

Interventions: Biological: A/H5N1
Biological: Placebo

First Posted Date: 2007-09-20

Last Posted Date: 2012-03-14

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 501

Registration Number: NCT00532792

Locations: 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
🇺🇸
Miami Research Associates, Miami, Florida, United States
🇺🇸
Solano Clinical Research, Vallejo, California, United States

and more 2 locations

ETEC Logistics Trial (TREK)

Phase 2

Completed

Conditions: Diarrhea

Interventions: Biological: Heat-Labile Enterotoxin of Escherichia coli (LT)
Biological: Placebo

First Posted Date: 2007-08-15

Last Posted Date: 2012-03-14

Lead Sponsor: Intercell USA, Inc.

Target Recruit Count: 201

Registration Number: NCT00516659

Locations: 🇺🇸
Advanced Biomedical Research, Hackensack, New Jersey, United States
🇺🇸
Asthma Allergy & Associates, Ithica, New York, United States
🇺🇸
Breco Research, Houston, Texas, United States

and more 13 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy